Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemmedchem|July 7, 2026
Quinoxaline-Based Monoamine Oxidase Inhibitors: Design Strategies, Synthesis, Structure-Activity Relationships, and Therapeutic Potential in Neurological Disorders: A Review From 1996 to 2026Sandeep Bindra, Ramajayan Pandian, Bijo Mathew, et al.
RSC Medicinal Chemistry|February 10, 2025
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitorsSandeep Bindra, Ehab M Mostafa, Mohamed A Abdelgawad, et al.
Current Computer-Aided Drug Design|April 8, 2025
Cholinesterase Inhibition and Anticancer Properties of [4-(Benzyloxy) phenyl]{Methylidene}hydrazinylidene]-1,3-dihydro-2H-Indol-2-ones Using Swiss Target-guided PredictionNaseer Maliyakkal, Parham Taslimi, Burak Tuzun, et al.
RSC Advances|September 3, 2024
FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 yearsSandeep Bindra, Kuntal Bose, Amrutha Chandran Thekkantavida, et al.
ACS Omega|November 11, 2024
Recent Progress in Synthetic and Natural Catechol-O-methyltransferase Inhibitors for Neurological DisordersSandeep Bindra, Ananya Datta, Haya Khader Ahmad Yasin, et al.
Chemistry & Biodiversity|June 15, 2026
Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone DerivativesSandeep Bindra, Won Kyeong Jeong, Muzammil Kabier, et al.
Molecular Diversity|August 15, 2024
Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromonesReshma Ipe, Jong Min Oh, Sunil Kumar, et al.
Pageof 1